Error processing SSI file
Error processing SSI file
Error processing SSI file
Error processing SSI file
Error processing SSI file
Error processing SSI file
Error processing SSI file
Error processing SSI file

Weekly Report: Influenza Summary Update

Week ending May 5, 2007-Week 18

Error processing SSI file

Synopsis:

During week 18 (April 29 May 5, 2007)*, influenza activity continued to decrease in the United States. Data from the U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories indicated a similar percentage of specimens testing positive for influenza during week 18 compared to week 17. The percentage of visits for ILI to sentinel providers decreased during week 18 and was below the national baseline for the seventh consecutive week. One state reported regional influenza activity; five states reported local influenza activity; the District of Columbia, New York City, and 31 states reported sporadic influenza activity; and 13 states reported no influenza activity. The number of jurisdictions reporting widespread or regional influenza activity decreased from three for week 17 to one for week 18. The percent of deaths due to pneumonia and influenza has remained below baseline levels for the entire influenza season to date.

Laboratory Surveillance*:

During week 18, WHO and NREVSS laboratories reported 1,140 specimens tested for influenza viruses, 117 (10.3%) of which were positive: five influenza A (H1) viruses, 53 influenza A (H3) viruses, 28 influenza A viruses that were not subtyped, and 31 influenza B viruses.

Since October 1, 2006, WHO and NREVSS laboratories have tested a total of 167,431 specimens for influenza viruses and 22,733 (13.5%) were positive. Among the 22,733 influenza viruses, 18,061 (79.4%) were influenza A viruses and 4,672 (20.6%) were influenza B viruses. Five thousand nine hundred one (32.7%) of the 18,061 influenza A viruses have been subtyped: 3,828 (64.9%) were influenza A (H1) viruses and 2,073 (35.1%) were influenza A (H3) viruses. Among specimens tested for influenza during the most recent three weeks (April 15 May 5, 2007), on a regional basis, only the New England, South Atlantic, and Pacific regions reported >10% of specimens testing positive.

INFLUENZA Virus Isolated


View WHO-NREVSS Regional Bar Charts | View Chart Data | View Full Screen

Composition of the 2006-07 Influenza Vaccine:

WHO has recommended that the 2007-08 trivalent influenza vaccine for the Northern Hemisphere contain A/Solomon Islands/3/2006-like (H1N1), A/Wisconsin/67/2005-like (H3N2), and B/Malaysia/2506/2004-like viruses. The influenza A (H1N1) component has been changed from the 2006-07 season vaccine components. A/Solomon Islands/3/2006 is a recent antigenic variant of the current vaccine strain A/New Caledonia/20/99. The influenza A (H3N2) and influenza B components remain the same. B/Ohio/1/2005 is antigenically equivalent to B/Malaysia/2506/2004. This recommendation was based on antigenic analyses of recently isolated influenza viruses, epidemiologic data, and post-vaccination serologic studies in humans.

Antigenic Characterization:

CDC has antigenically characterized 719 influenza viruses [358 influenza A (H1), 152 influenza A (H3) viruses, and 209 influenza B viruses] collected by U.S. laboratories since October 1, 2006.

Influenza A (H1) [358]

Three hundred thirty-one (92%) of the 358 viruses characterized were similar to A/New Caledonia/20/99-like, which is the influenza A (H1) component of the 2006-07 influenza vaccine.

Twenty-six (7%) of the 358 viruses showed somewhat reduced titers with antisera produced against A/New Caledonia/20/99 and are similar to A/Solomon Islands/3/2006-like. A/Solomon Islands/3/2006 is a recent antigenic variant of A/New Caledonia/20/99.

One virus showed somewhat reduced titers with antisera produced against A/New Caledonia/20/99 and to A/Solomon Islands/3/2006.

Influenza A (H3) [152]

Forty-one (27%) of the 152 viruses were characterized as A/Wisconsin/67/2005-like, which is the influenza A (H3) component of the 2006-07 influenza vaccine.

One hundred and eleven (73%) of the 152 viruses showed somewhat reduced titers with antisera produced against A/Wisconsin/67/2005.

Influenza B (B/Victoria/02/87 and B/Yamagata/16/88 lineages) [209]
Victoria lineage [159]
One hundred and fifty-nine (76%) of the 209 influenza B viruses characterized belong to the B/Victoria lineage of viruses.

o Eighty-five (53%) of these 159 viruses were similar to B/Ohio/01/2005, the B component of the 2006-07 influenza vaccine.

o Seventy-four (47%) of these 159 viruses showed somewhat reduced titers with antisera produced against B/Ohio/01/2005.

Yamagata lineage [50]
Fifty (24%) of the 209 influenza B viruses characterized belong to the B/Yamagata lineage of viruses.

Pneumonia and Influenza (P&I) Mortality Surveillance*:

During week 18, 6.7% of all deaths were reported as due to pneumonia or influenza. This percentage is below the epidemic threshold of 7.3% for week 18.

Pneumonia And Influenza Mortality

View Full Screen

Influenza-Associated Pediatric Mortality*:

Three influenza-associated pediatric deaths were reported during week 18. Since October 1, 2006, CDC has received 56 reports of influenza-associated pediatric deaths that occurred during the current season.

Influenza-Associated Pediatric Hospitalizations*:

Laboratory-confirmed influenza-associated pediatric hospitalizations are monitored in two population-based surveillance networks: the Emerging Infections Program (EIP) and the New Vaccine Surveillance Network (NVSN).

During November 5, 2006 to April 28, 2007, the preliminary laboratory-confirmed influenza-associated hospitalization rate for children 0-4 years old in the NVSN was 3.02 per 10,000.

NVSN laboratory-confirmed influenza-associated hospitalizations for children 0-4 years old
View Full Screen

During October 1, 2006 to April 28, 2007, the preliminary laboratory-confirmed influenza-associated hospitalization rate reported by the EIP for children 017 years old was 0.81 per 10,000. For children aged 0-4 years and 5-17 years, the rate was 1.62 per 10,000 and 0.23 per 10,000, respectively.

EIP Influenza Laboratory-Confirmed Cumulative Hospitalization Rates for Children Aged 0-4 and 5-17 years, 2005-06 and Previous 2 Seasons
View Full Screen

Influenza-like Illness Surveillance*:

During week 18, 1.0%** of patient visits to U.S. sentinel providers were due to ILI. This percentage is below the national baseline*** of 2.1%. All nine surveillance regions**** reported ILI below their region-specific baseline***:

Bar Chart for Influenza-like Illness
View Sentinel Providers Regional Charts | View Chart Data | View Full Screen

Influenza Activity as Assessed by State and Territorial Epidemiologists*:

During week 18, the following influenza activity was reported:

Regional activity was reported by one state (New York).

Local activity was reported by five states (Connecticut, Hawaii, Maine, Maryland, and Montana).

Sporadic activity was reported by the District of Columbia, New York City, and 31 states (Alaska, Arizona, California, Colorado, Delaware, Florida, Georgia, Illinois, Indiana, Kansas, Kentucky, Massachusetts, Michigan, Minnesota, Missouri, Nevada, New Hampshire, New Jersey, New Mexico, North Carolina, North Dakota, Pennsylvania, South Carolina, South Dakota, Tennessee, Utah, Vermont, Virginia, Washington, Wisconsin, and Wyoming).

Alabama, Arkansas, Idaho, Iowa, Louisiana, Mississippi, Nebraska, Ohio, Oklahoma, Oregon, Rhode Island, Texas, and West Virginia reported no influenza activity.

U. S. map for Weekly Influenza Activity
View Full Screen

--------------------------------------------------------------------------------

 

Foot notes

Report prepared May 11, 2007 Error processing SSI file
Error processing SSI file
Error processing SSI file